Qingdao Baheal Medical INC. (SHE:301015)
China · Delayed Price · Currency is CNY 24.75
-0.17 (-0.68%)
May 8, 2026, 3:09 PM CST
SHE:301015 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Net Income | 610.86 | 571.93 | 691.59 | 712.06 | 502.09 | 421.64 |
Depreciation & Amortization | 119.06 | 119.06 | 74.48 | 86.14 | 54.86 | 41.18 |
Other Amortization | 10.92 | 10.92 | 17.73 | 5.27 | 6.67 | 12.01 |
Loss (Gain) From Sale of Assets | -0.52 | -0.52 | -0.93 | 6.57 | -0.57 | -0.1 |
Asset Writedown & Restructuring Costs | -25.65 | -25.65 | 0.46 | 0.35 | 0.04 | 0.01 |
Loss (Gain) From Sale of Investments | -23.15 | -23.15 | -56.85 | -48.5 | 8.87 | -9.77 |
Provision & Write-off of Bad Debts | - | - | 11.26 | 32.87 | 13.08 | -1.53 |
Other Operating Activities | -204.73 | 111.27 | 163.65 | 128.92 | 36.81 | 56.33 |
Change in Accounts Receivable | 150.19 | 150.19 | -85.14 | -104.15 | -386.9 | -373.68 |
Change in Inventory | -11.69 | -11.69 | -70.23 | -57.96 | -70.37 | -10.89 |
Change in Accounts Payable | 61.81 | 61.81 | 64.5 | 49.02 | 148.45 | 39.62 |
Change in Other Net Operating Assets | - | - | - | - | - | 0.2 |
Operating Cash Flow | 657.38 | 934.45 | 813.85 | 799.5 | 305.75 | 181.3 |
Operating Cash Flow Growth | -24.13% | 14.82% | 1.80% | 161.48% | 68.65% | - |
Capital Expenditures | -309.23 | -288.93 | -303.99 | -185.49 | -105.32 | -27.49 |
Sale of Property, Plant & Equipment | 0.4 | 0.4 | 0.79 | 6.09 | 0.91 | 0.13 |
Cash Acquisitions | - | - | -3.39 | - | -5.76 | - |
Divestitures | - | - | 4.43 | 16.35 | 7.78 | 6.11 |
Investment in Securities | -274.2 | -307.98 | -437.83 | -137.39 | -18.24 | -4.48 |
Other Investing Activities | 8.15 | 7.7 | 7.68 | 4.73 | 3.3 | 2.9 |
Investing Cash Flow | -574.88 | -588.81 | -732.32 | -295.71 | -117.33 | -22.82 |
Short-Term Debt Issued | - | - | - | 68.43 | 1,571 | 1,188 |
Long-Term Debt Issued | - | 2,288 | 2,198 | 1,434 | - | - |
Total Debt Issued | 2,670 | 2,288 | 2,198 | 1,503 | 1,571 | 1,188 |
Short-Term Debt Repaid | - | - | -304.96 | -21.1 | -1,530 | -1,374 |
Long-Term Debt Repaid | - | -1,260 | -938.63 | -1,460 | -33.82 | -26.09 |
Total Debt Repaid | -1,408 | -1,260 | -1,244 | -1,481 | -1,564 | -1,400 |
Net Debt Issued (Repaid) | 1,262 | 1,027 | 954.32 | 21.62 | 7.14 | -212.25 |
Issuance of Common Stock | - | - | - | - | - | 401.86 |
Common Dividends Paid | -471.94 | -467.57 | -449.86 | -440.11 | -402.22 | -55.72 |
Other Financing Activities | -184.58 | -194.16 | -499.79 | 85.29 | -148.5 | -95.85 |
Financing Cash Flow | 605.74 | 365.48 | 4.67 | -333.2 | -543.58 | 38.04 |
Foreign Exchange Rate Adjustments | -12.45 | -9.73 | 2.21 | 0.72 | 5.87 | -1.18 |
Net Cash Flow | 675.78 | 701.4 | 88.4 | 171.31 | -349.29 | 195.33 |
Free Cash Flow | 348.15 | 645.52 | 509.86 | 614.01 | 200.43 | 153.81 |
Free Cash Flow Growth | -40.72% | 26.61% | -16.96% | 206.34% | 30.31% | - |
Free Cash Flow Margin | 4.67% | 8.60% | 6.30% | 7.44% | 2.67% | 2.18% |
Free Cash Flow Per Share | 0.65 | 1.21 | 0.94 | 1.15 | 0.38 | 0.31 |
Cash Income Tax Paid | 636.25 | 641.35 | 632.97 | 600.08 | 459.8 | 384.21 |
Levered Free Cash Flow | 117.59 | 499.13 | 791.34 | 340.46 | 171.77 | 45.79 |
Unlevered Free Cash Flow | 117.59 | 499.13 | 841.39 | 385.29 | 208.06 | 83.96 |
Change in Working Capital | 170.59 | 170.59 | -87.55 | -124.17 | -316.12 | -338.47 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.